Nuzenio

Maze Therapeutics

Maze Therapeutics news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 9 latest news signals 4 publisher sources 100/100 entity strength

Latest news

Timeline

Mon, 10 Aug 2026 19:38:28 GMTMaze Therapeutics (NASDAQ:MAZE) Trading Down 6.8% - Should You Sell? - MarketBeat
Fri, 07 Aug 2026 14:29:07 GMTMaze Therapeutics Inc (MAZE) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Wed, 05 Aug 2026 20:09:36 GMTMaze Therapeutics, Inc. (MAZE) CEO Coloma sells 34,501 shares via trusts - Stock Titan
Mon, 03 Aug 2026 20:09:41 GMTMAZE (NASDAQ: MAZE) insider trusts detail stock sales in Form 144 - Stock Titan
Sat, 01 Aug 2026 10:42:24 GMTMaze Therapeutics, Inc. $MAZE Stake Reduced by Janus Henderson Group PLC - MarketBeat
Sat, 01 Aug 2026 01:57:10 GMTMAZE PE Ratio & Valuation, Is MAZE Overvalued - Intellectia AI

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Maze Therapeutics.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

4 distinct publisher/source names are currently connected to this entity page.